click below
click below
Normal Size Small Size show me how
Grad Pharm
drugs
| Question | Answer |
|---|---|
| Acyclovir | HSV drug. Viral TK first phosphorylates. |
| Cidofovir | HSV drug. Doesn't need viral TK. Less specific |
| AZT | Azidothymidine. AZT-PPP Inhibits RT. Also causes chain termination |
| NNRTI | Non nucleoside reverse transcriptase inhibitor. Noncompetitive inhibitor. High resistance. |
| Protease Inhibitor | HIV drug. Stops protease needed to cleave viral proteins to activate them |
| Pleconaril | For Rhinovirus. Block viral uncoating and attachement to epithelial cells. |
| Bephenium | Antihelminthic. block reuptake of ACh. Spastic paralysis |
| Pyrantel | inhibits ACh esterase. Spastic Paralysis |
| Piperazine | Flaccid paralysis. Mechanism Unclear |
| Metronidazole | nitroaromatic group accepts electron. Produces radical species that causes DNA damage in anerobes.Through Nitroso compounds |
| Pentamidine | Anti Trypanosome. Actively pumped into parasite. |
| Difluoromethylmithine (DFMO) | irreversibly binds to ornithine decarboxylase. Enzyme has long halflife in trypanazome |
| Aspirin | Nonselective COX inbibitor. irreversible |
| Ibuprofen, naproxen, indomethacin | Non selective COX inbibitor, reversible |
| Celecoxib, rofecoxib, valdecoxib | Selective COX2 inhibitor. Rofecoxib, and valdecoxib show cardiovascular risk |
| Estradiol, ethinyl estradiol, quinestrol | Agonist of estrogen |
| Tamoxifen | Antagonist of estrogen, for ER positive breast cancer |
| Enclomephene | Treatment for infertility. contraceptive activity |
| 19-nortestosterone, norethindrone, norethnodrel | Agonist of progestin. Hormone repalcement therapy |
| Mifepristone RU486 | Antagonist of progestins. Abortions |
| testosterone | agonist of androgen |
| finasteride, flutimide | antagonist of androgen |
| hydrocortisone, dexamethasone, prednisolone | agonist of adrenalcorticosteroids |
| Rituximab | chimeric antibody with human constant region and mouse variable. targets and kills B-cells with CD20. for lymphoma |
| Dipyridamole | Adenosine deaminase inhibitor. Anti platelet agent |
| Ticlopidine | P2Y12 antagonist. Noncompetitive irreversible binding to receptor. neutropenia |
| Clopidogrel | Plavix. less neutropenia P2Y12 antagonist |
| Prasugrel | improve on plavix, but higher bleeding risk. |
| Ticagrelor | reversible P2y12 antagonist. More bleeding. good efficacy. |
| Abciximab | GPIIBIIIa receptor antagonist humanized mouse antibody |
| Eptifibatide | GPIIBIIIa antagonist. RGD cyclic peptide |
| Tirofiban | small molecule RGD mimic |
| Vorapaxar | PAR1 (Thrombin receptor antagonist) |
| Heparin | antithrombin inactivation of Factor Xa. No oral bioavailibility |
| Warfarin | Vitamin K dependent process. Many indirect effects. Block glutamic acid carboxylation. Slow |
| Rivaroxaban | inhibitor factor xa. orally bioavailible. long t1/2 |
| Dabigatran | direct thrombin inhibitor. orally bioavailible |
| Streptokinase | Fibrinolytic. Binds to plasminogen and activates it. For MI. Large dose needed. |
| Altepase | Recombinant tissue Plasminogen activator (tPA). Serine protease. Short halflife. |